The role of soluble guanylyl cyclase in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013
A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014
Resistive breathing aggravates endotoxin-induced lung inflammation Source: International Congress 2014 – Critical illness and therapeutic interventions Year: 2014
Repeated lipopolysaccharide stimulation causes corticosteroid insensitive inflammation in lung via phosphoinositide-3-kinase δ signaling Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
The role of Clara cell senescence in the pathogenesis of COPD Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence Year: 2014
A soluble guanylate cyclase stimulator, BAY 41-8543, preserves pulmonary artery endothelial function in experimental pulmonary embolism Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013
Pharmacological characterization of the anti-oxidant activity of N-acetylcysteine in an ex vivo model of COPD exacerbation Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016
Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model) Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014
Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013
LATE-BREAKING ABSTRACT: The involvement of serotonin in cigarette smoke-induced airway remodeling in mice Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016
Afferent vagal modulation of ventilation and compensatory capacity of the respiratory system at obstructive lung disease with central hypervolemia: A modeling study Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning Year: 2014
Mucociliary function in bronchial epithelium of COPD and non-COPD patients: In vitro assessment of the effects of fluid restriction Source: International Congress 2014 – Cell biology 2014 Year: 2014
Down-regulation of soluble guanylyl cyclase in asthma contributes to airway hyperreactivity Source: Eur Respir J 2005; 26: Suppl. 49, 581s Year: 2005
Effects of dopamine on the elevated airway tone by histamine and methacholine in rabbits Source: International Congress 2014 – Clinical physiology and respiratory muscles Year: 2014
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014
Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Additive layer manufacturing of physiologically realistic patient specific airway models for study of flow modifications in asthma and COPD Source: Annual Congress 2013 –Functional imaging Year: 2013
TRPV4 and activation of airway sensory nerves: The role of ATP Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015
Alteration of the immune response to streptococcus pneumoniae during COPD exacerbation in mice Source: Annual Congress 2013 –COPD and infections Year: 2013
Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016